Stefania Kerekes

Ms. Stefania Kerekes


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
SKStefania Kerekes
Stefania Kerekes
MJMengdi Ji
Mengdi Ji
SSShu-Fang Shih
Shu-Fang Shih
HCHao-Yuan Chang
Hao-Yuan Chang
Harapan HarapanHarapan Harapan
Harapan Harapan
AWAbram Wagner
Abram Wagner
Controlling the spread of SARS-CoV-2 will require high vaccination coverage, but acceptance of the vaccine could be impacted by perceptions of vaccine safety and effectiveness. The aim of this study was to characterize how vaccine safety and effectiveness impact acceptance of a vaccine, and whether this impact varied over time or across socioeconomic and demographic groups. Repeated cross-sectional surveys of an opt-in internet sample were conducted in 2020 in the US, mainland China, Taiwan, Malaysia, Indonesia, and India. Individuals were randomized into receiving information about a hypothetical COVID-19 vaccine with different safety and effectiveness profiles (risk of fever 5% vs. 20% and vaccine effectiveness 50% vs. 95%). We examined the effect of the vaccine profile on vaccine acceptance in a logistic regression model, and included interaction terms between vaccine profile and socioeconomic/demographic variables to examine the differences in sensitivity to the vaccine profile. In total, 12,915 participants were enrolled in the six-country study, including the US (4054), China (2797), Taiwan (1278), Malaysia (1497), Indonesia (1527), and India (1762). Across time and countries, respondents had stronger preferences for a safer and more effective vaccine. For example, in the US in November 2020, acceptance was 3.10 times higher for a 95% effective vaccine with a 5% risk of fever, vs a vaccine 50% effective, with a 20% risk of fever (95% CI: 2.07, 4.63). Across all countries, there was an increase in the effect of the vaccine profile over time (p < 0.0001), with stronger preferences for a more effective and safer vaccine in November 2020 compared to August 2020. Sensitivity to the vaccine profile was also stronger in August compared to November 2020, in younger age groups, among those with lower income; and in those that are vaccine hesitant. Uptake of COVID-19 vaccines could vary in a country based upon effectiveness and availability. Effective communication tools will need to be developed for certain sensitive groups, including young adults, those with lower income, and those more vaccine hesitant.

4 August 2021 in Challenges
Verified
Journal Article
Open access
PDF file
SKStefania Kerekes
Stefania Kerekes
ABAriadna Georgiana-Eugenia Badea
Ariadna Georgiana-Eugenia Badea
Dragos PaunDragos Paun
Dragos Paun
There has been a debate on the efficiency of lockdown policies worldwide, and several researchers have studied this aspect by trying to implement different statistical models. The aim of the research was to compare two countries with similar lockdown policies and observe the impact of the total lockdown policy on the spread of the COVID-19 disease. Taking in consideration that the total lockdown in Romania lasted for 52 days and in Hungary for 54 days, we would like to see how the infection rate changed with every week of the lockdown by obtaining an average for every week (7 days) divided by the total lockdown days in each country. The values that we took in consideration are as follows: the daily infected cases, the daily infected cases/million, the daily cases of death and the daily cases of death/million in both countries. We tried to apply the same rule after the end of the total lockdown and observe the outcomes. The results showed that the minimum number of days to observe the effects of total lockdown and the effects after the lockdown was 21 (3 weeks) in both countries.